Wednesday, 24 Apr 2019

You are here

Maternal RA Increases Offspring Risk of Autoimmune Disorders

A Danish population study suggests that fetal exposure to maternal rheumatoid arthritis (RA) results in an increased offspring risk of thyroid disease, epilepsy and RA, compared to children born to mothers without RA.

Researchers examined a possible association between maternal RA and 15 select chronic diseases in the offspring in a national cohort study using Danish health registries. They examined 2106 children born to RA women (exposed) between 1989 and 2013 and compared outcomes to 1,378,539 children born by women without RA (unexposed).

Exposure to maternal RA resulted in an increased offspring risk for:

  • Thyroid diseases (hazard ratio [HR] 2.19; 95% confidence interval [95% CI] 1.14–4.21)
  • Epilepsy (HR 1.61; 95% CI 1.16–2.25)
  • RA 2.89 (HR 95% CI 2.06–4.05).

Increased but not significant were the odds of developing anxiety, personality disorders and chronic lung disease, including asthma (HR range of 1.15–1.16).

This registry, population-based analysis suggests in utero exposure to maternal RA is associated with an increased risk of select autoimmune conditions, including RA.  While there was a nearly 2-3 fold risk of these autoimmune conditions the overall individual risk still remained quite low (RA exposed risk to offspring was 1.6% compared with 0.7% in unexposed).

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

Statins in RA Patients Without CVD: Nonsignificant Results

Patients with RA, but without CV disease, who were treated with atorvastatin appeared to experience cardiovascular (CV) benefits similar to what has been observed in other populations, with a risk reduction of approximately one-third, according to a large, but prematurely terminated, trial in the U.K.

Increasing Prevalence and Consequences of Interstitial Lung Disease in RA

Interstitial lung disease (ILD) has been a hot topic in numerous journals recently with reports of increasing incidence and links to disease activity.

RheumNowLive On Demand: MTX Impact in RA - Dr. Michael Weinblatt

A clip from RheumNow Live On Demand. You can access the full library of content from the meeting.

RheumNowLive On Demand: Pre-Clinical RA - Dr. Michael Holers

A clip from RheumNow Live On Demand. You can access the full library of content from the meeting.

Artificial Intelligence to Predict Rheumatoid Disease Activity

A recent study in JAMA Network Open shows that artificial intelligence models can use electronic health record data to prognosticate future patient outcomes in rheumatoid arthritis (RA).